During the February 9, 2023 Executive Business Meeting, Senate Judiciary Committee reported Interagency Patent Coordination and Improvement Act of 2023, Prescription Pricing for the People Act of 2023, Preserve Access to Affordable Generics and Biosimilars Act, and more.
It is hard to predict whether a given bill will gain traction, but when the Senate Judiciary Committee reports out five bipartisan bills targeting pharmaceutical patents and pricing, it.
Drug companies that raise prescription drug prices faster than the rate of inflation will pay rebates to the federal government or face fines. The Centers for Medicare and Medicaid Services on Thursday released the initial guidance on the Medicare Prescription Drug Inflation Rebate Program. Drug companies will be required to pay rebates to the Medicare Trust Fund for raising